Crocker Capital
3
3M
2
0.33
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the San Francisco. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Crocker Capital, startups are often financed by U.S. Department of the Treasury, Palo Alto Investors. The meaningful sponsors for the fund in investment in the same round are Volcano Capital, Palo Alto Investors, New England Partners. In the next rounds fund is usually obtained by Volcano Capital, U.S. Department of the Treasury, SalubrisBio.
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2006. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Mercator MedSystems
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Health Care (2)
- Medical Device (2)
- Medical (2)
- Therapeutics (1) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| A&G Pharmaceutical | 08 Sep 2005 | Biotechnology, Drug Discovery, Pharmaceutical, Therapeutics | Early Stage Venture | 2M | United States, Maryland, Columbia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.